Canada markets closed

XORTX Therapeutics Inc. (XRTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.5800-0.0200 (-0.77%)
At close: 04:00PM EDT
2.5000 -0.08 (-3.10%)
After hours: 05:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.40M
Enterprise Value 3.58M
Trailing P/E 1.47
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.01
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.09

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-95.64%
S&P500 52-Week Change 326.14%
52 Week High 367.7160
52 Week Low 31.9800
50-Day Moving Average 33.2108
200-Day Moving Average 315.3686

Share Statistics

Avg Vol (3 month) 350.98k
Avg Vol (10 day) 315.89k
Shares Outstanding 52.9M
Implied Shares Outstanding 63.21M
Float 82.21M
% Held by Insiders 14.82%
% Held by Institutions 19.33%
Shares Short (Apr 30, 2024) 48.8k
Short Ratio (Apr 30, 2024) 40.49
Short % of Float (Apr 30, 2024) 40.31%
Short % of Shares Outstanding (Apr 30, 2024) 40.30%
Shares Short (prior month Mar 28, 2024) 421.1k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:9
Last Split Date 3Nov 14, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.00%
Return on Equity (ttm)-57.92%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.86M
Net Income Avi to Common (ttm)-3.34M
Diluted EPS (ttm)-1.3800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.84M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)14.04k
Total Debt/Equity (mrq)0.56%
Current Ratio (mrq)13.68
Book Value Per Share (mrq)1.02

Cash Flow Statement

Operating Cash Flow (ttm)-5.4M
Levered Free Cash Flow (ttm)-2.96M